Impact Factor 3.161 | CiteScore 3.13
More on impact ›
The section is aimed at publishing high quality research in all fields of psychopharmacology. Special attention is given to affective and substance use disorders, stress-related disturbances, emotion, cognition and impulse-related pathologies.
The section is aimed at publishing high quality research in all fields of psychopharmacology. Special attention is given to affective and substance use disorders, stress-related disturbances, emotion, cognition and impulse-related pathologies. We are interested to receive publications from all areas of preclinical and clinical research. One of the primary missions of this section is to promote research aimed at the characterization of novel biological targets and development of new medication for the treatment of CNS disorders. Also relevant to the section are studies aimed at investigating behavioural and neuronal mechanisms associated with psychiatric disease and to understand their molecular, genetic and epigenetic basis. This section additionally covers aspects associated with gender differences in neuropsychiatric pathologies and drug response.
Our ultimate aim is to contribute to improve human health and to enhance the quality of life by promoting research in psychopharmacology.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, PsycINFO, EMBASE, Science Citation Index Expanded, CLOCKSS, Social Science Citation Index
PMCID: all published articles receive a PMCID
Psychopharmacology welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Correction, Editorial, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge and Systematic Review.
All manuscripts must be submitted directly to the section Psychopharmacology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org